News & Events

If CAR-T therapy is the “star” of the immunotherapy field, then natural killer (NK) cell therapy is poised to become the next “top trend.” With its three core advantages—readiness for use, safety...

March 2026 — Researchers at Stanford University School of Medicine have reported a new approach to engineering immune cells capable of detecting metabolic signals released by tumors, potentially impr...

Hillgene has recently been officially recognized as a “Specialized and Innovative” enterprise, a national designation granted by the Chinese government to companies that demonstrate outstanding capa...

Meribank Biotech has recently announced a new collaboration focused on upgrading manufacturing capabilities for NK cell therapies, including process optimization and the integration of AI-driven quali...

The recent collaboration between MiNK Therapeutics and C-Further to advance a PRAME-targeted iNKT cell therapy for pediatric cancers reflects more than a single pipeline update. As noted in recent ind...

Iovance Biotherapeutics announced new clinical results for its tumor-infiltrating lymphocyte (TIL) therapy Lifileucel in patients with soft tissue sarcoma, highlighting the potential expansion of TIL ...

As spring ushers in a new beginning, everything is renewed with vitality. On March 6, 2026, Hillgene successfully held its Spring Gala themed “Upgrading Capabilities · Expanding Horizons · Shaping ...

March 2026 — Global Biotech NewsLentiviral vector technology continues to play a central role in the evolution of CAR-T cell therapies, as researchers advance strategies aimed at delivering chimeric ...

On February 19, 2026, Japan's Ministry of Health, Labour and Welfare (MHLW) granted conditional and time-limited approval to the world's first two induced pluripotent stem cell (iPSC)–based r...

February 2026 — Global Biotech NewsShanghai, China / Global — CARsgen Therapeutics Holdings Ltd., a clinical-stage biotechnology company focused on innovative chimeric antigen receptor T-cell (CAR-T...

February 2026 — Industry NewsThe global cell and gene therapy (CGT) sector continues to expand, with recent industry data highlighting a combination of strong product revenues, increasing regulatory ...

February 2026 — Global Biotech NewsSan Francisco, CA / USA — The U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for SRN-101, an AAV-based immuno-ge...